Synopsis

Source of validity: Scientific
Rating (out of 5): 3

LH01-myoviridae is a bacteriophage, a type of virus that specifically infects and destroys bacteria. Its use in treating abscesses is supported by emerging scientific evidence, primarily from preclinical studies and early-stage clinical research. Abscesses are localized collections of pus caused by bacterial infection, often resistant to antibiotics due to biofilm formation and multidrug-resistant bacterial strains. Bacteriophage therapy, including the use of LH01-myoviridae, has been explored as an alternative or adjunct to conventional antibiotics, especially in cases where standard treatments fail.

Scientific studies have shown that LH01-myoviridae can effectively lyse certain strains of pathogenic bacteria, notably Staphylococcus aureus, which is a common cause of abscesses. Several in vitro and animal model experiments have demonstrated its ability to reduce bacterial load and promote healing in soft tissue infections, including abscesses. The evidence is still developing, with limited but promising compassionate use cases in humans.

However, large-scale, randomized controlled trials are lacking, and the regulatory framework for medical phage use is still evolving. Therefore, while there is scientific rationale and preclinical evidence supporting the use of LH01-myoviridae for abscesses, the overall strength of clinical evidence is moderate (rated 3/5). Ongoing research may further clarify its efficacy and safety in broader clinical settings.

More about LH01-myoviridae
More about Abscesses

Other ingredients used for Abscesses

Other health conditions supported by LH01-myoviridae

Products containing LH01-myoviridae

Designs For Health Probiophage DF™
Designs For Health Probiophage DF™